News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,460 Results
Type
Article (17004)
Company Profile (33)
Press Release (248423)
Multimedia
Podcasts (14)
Webinars (4)
Section
Business (81386)
Career Advice (580)
Deals (14362)
Drug Delivery (25)
Drug Development (34158)
Employer Resources (40)
FDA (6153)
Job Trends (6245)
News (134931)
Policy (10253)
Tag
Academia (747)
Accelerated approval (2)
Adcomms (4)
Allergies (40)
Alliances (14422)
ALS (47)
Alzheimer's disease (501)
Antibody-drug conjugate (ADC) (49)
Approvals (6211)
Artificial intelligence (125)
Autoimmune disease (16)
Automation (10)
Bankruptcy (115)
Best Places to Work (4790)
BIOSECURE Act (2)
Biosimilars (48)
Biotechnology (24)
Bladder cancer (56)
Brain cancer (16)
Breast cancer (179)
Cancer (1253)
Cardiovascular disease (91)
Career advice (473)
Career pathing (6)
CAR-T (55)
Cell therapy (195)
Cervical cancer (11)
Clinical research (29509)
Collaboration (414)
Company closure (1)
Compensation (266)
Complete response letters (1)
COVID-19 (910)
CRISPR (19)
C-suite (100)
Cystic fibrosis (42)
Data (1397)
Decentralized trials (1)
Denatured (4)
Depression (20)
Diabetes (122)
Diagnostics (2211)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (11)
Drug discovery (56)
Drug pricing (39)
Drug shortages (8)
Duchenne muscular dystrophy (43)
Earnings (49123)
Editorial (11)
Employer branding (7)
Employer resources (34)
Events (43149)
Executive appointments (374)
FDA (6894)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (399)
Gene editing (46)
Generative AI (9)
Gene therapy (149)
GLP-1 (369)
Government (1325)
Grass and pollen (4)
Guidances (141)
Healthcare (6618)
Huntington's disease (5)
IgA nephropathy (17)
Immunology and inflammation (49)
Indications (14)
Infectious disease (981)
Inflammatory bowel disease (60)
Inflation Reduction Act (5)
Influenza (27)
Intellectual property (53)
Interviews (112)
IPO (7975)
IRA (14)
Job creations (1757)
Job search strategy (408)
Kidney cancer (6)
Labor market (18)
Layoffs (158)
Leadership (2)
Legal (2168)
Liver cancer (36)
Lung cancer (193)
Lymphoma (83)
Machine learning (3)
Management (12)
Manufacturing (131)
MASH (47)
Medical device (4728)
Medtech (4728)
Mergers & acquisitions (6724)
Metabolic disorders (326)
Multiple sclerosis (48)
NASH (10)
Neurodegenerative disease (46)
Neuropsychiatric disorders (9)
Neuroscience (781)
NextGen: Class of 2025 (2369)
Non-profit (1578)
Now hiring (9)
Obesity (162)
Opinion (58)
Ovarian cancer (43)
Pain (38)
Pancreatic cancer (38)
Parkinson's disease (82)
Partnered (9)
Patents (94)
Patient recruitment (53)
Peanut (18)
People (15944)
Pharmaceutical (9)
Pharmacy benefit managers (4)
Phase I (8096)
Phase II (12973)
Phase III (11012)
Pipeline (1010)
Policy (37)
Postmarket research (1070)
Preclinical (2708)
Press Release (44)
Prostate cancer (59)
Psychedelics (8)
Radiopharmaceuticals (86)
Rare diseases (166)
Real estate (2115)
Recruiting (13)
Regulatory (7607)
Reports (17)
Research institute (678)
Resumes & cover letters (117)
Rett syndrome (5)
RNA editing (3)
RSV (20)
Schizophrenia (34)
Series A (61)
Series B (44)
Service/supplier (5)
Sickle cell disease (23)
Special edition (7)
Spinal muscular atrophy (62)
Sponsored (9)
Startups (1228)
Stomach cancer (3)
Supply chain (33)
Tariffs (14)
The Weekly (10)
Vaccines (295)
Venture capitalists (8)
Weight loss (118)
Women's health (11)
Worklife (3)
Date
Today (86)
Last 7 days (624)
Last 30 days (1941)
Last 365 days (16307)
2025 (6685)
2024 (15104)
2023 (15017)
2022 (18874)
2021 (20133)
2020 (17970)
2019 (15532)
2018 (11807)
2017 (10742)
2016 (11550)
2015 (44338)
2014 (19407)
2013 (5929)
2012 (6496)
2011 (7322)
2010 (6287)
Location
Africa (366)
Alabama (17)
Alaska (3)
Arizona (59)
Arkansas (3)
Asia (16148)
Australia (2620)
California (3355)
Canada (977)
China (234)
Colorado (140)
Connecticut (183)
Delaware (118)
Europe (39206)
Florida (404)
Georgia (89)
Idaho (18)
Illinois (280)
India (13)
Indiana (184)
Iowa (4)
Japan (108)
Kansas (35)
Kentucky (9)
Louisiana (7)
Maine (29)
Maryland (403)
Massachusetts (2556)
Michigan (133)
Minnesota (161)
Mississippi (1)
Missouri (54)
Montana (11)
Nebraska (5)
Nevada (37)
New Hampshire (24)
New Jersey (1071)
New Mexico (5)
New York (875)
North Carolina (419)
North Dakota (2)
Northern California (1475)
Ohio (85)
Oklahoma (4)
Oregon (14)
Pennsylvania (626)
Puerto Rico (2)
Rhode Island (4)
South America (469)
South Carolina (7)
Southern California (1233)
Tennessee (71)
Texas (502)
United States (12204)
Utah (104)
Virginia (73)
Washington D.C. (26)
Washington State (300)
West Virginia (2)
Wisconsin (47)
265,460 Results for "15".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Lexeo Trims 15% of Workforce, Shifts Focus to Lead Cardiac Programs
Lexeo wants to more quickly move investigational gene therapy LX2006 into a registrational study and hopes for a potential efficacy readout in 2027.
May 12, 2025
·
1 min read
·
Angela Gabriel
Press Releases
BioSyent Schedules First Quarter Earnings Release for May 15, 2025
May 9, 2025
·
1 min read
Press Releases
Innate Pharma Announces €15M Investment by Sanofi
April 24, 2025
·
6 min read
Press Releases
Cue Biopharma to Host Virtual Investor Event on May 15, 2025
May 9, 2025
·
8 min read
Press Releases
Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025
May 12, 2025
·
2 min read
Press Releases
Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025
May 8, 2025
·
1 min read
Press Releases
Sickle Cell Disease Treatment Market is Rising Rapidly with 15.6% CAGR by 2032
May 12, 2025
·
1 min read
Press Releases
PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025
May 1, 2025
·
2 min read
Press Releases
Olfactive Biosolutions to Present May 15 at FoodTech World Cup Conference Final
April 30, 2025
·
2 min read
Press Releases
Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference
April 23, 2025
·
2 min read
1 of 26,546
Next
